Literature DB >> 25332325

Isoflavone supplement composition and equol producer status affect gene expression in adipose tissue: a double-blind, randomized, placebo-controlled crossover trial in postmenopausal women.

Vera van der Velpen1, Anouk Geelen1, Peter C H Hollman1, Evert G Schouten1, Pieter van 't Veer1, Lydia A Afman1.   

Abstract

BACKGROUND: Isoflavone supplements, consumed by women experiencing menopausal symptoms, are suggested to have positive effects on menopause-related adiposity and cardiovascular disease risk profile, but discussions about their safety are still ongoing.
OBJECTIVE: The objective was to study the effects of an 8-wk consumption of 2 different isoflavone supplements compared with placebo on whole-genome gene expression in the adipose tissue of postmenopausal women.
DESIGN: This double-blind, randomized, placebo-controlled crossover intervention consisted of 2 substudies, one with a low-genistein (LG) supplement (56% daidzein + daidzin, 16% genistein + genistin, and 28% glycitein + glycitin) and the other with a high-genistein (HG) supplement (49% daidzein + daidzin, 41% genistein + genistin, and 10% glycitein + glycitin). Both supplements provided ∼ 100 mg isoflavones/d (aglycone equivalents). After the 8-wk isoflavone and placebo period, whole-genome arrays were performed in subcutaneous adipose tissue of postmenopausal women (n = 26 after LG, n = 31 after HG). Participants were randomized by equol-producing phenotype, and data analysis was performed per substudy for equol producers and nonproducers separately.
RESULTS: Gene set enrichment analysis showed downregulation of expression of energy metabolism-related genes after LG supplementation (n = 24) in both equol-producing phenotypes and oppositely regulated expression for equol producers (down) and nonproducers (up) after HG supplementation (n = 31). Expression of inflammation-related genes was upregulated in equol producers but downregulated in nonproducers, independent of supplement type. Only 4.4-7.0% of the genes with significantly changed expression were estrogen responsive. Body weight, adipocyte size, and plasma lipid profile were not affected by isoflavone supplementation.
CONCLUSIONS: Effects of isoflavones on adipose tissue gene expression were influenced by supplement composition and equol-producing phenotype, whereas estrogen-responsive effects were lacking. LG isoflavone supplementation resulted in a caloric restriction-like gene expression profile for both producer phenotypes and pointed toward a potential beneficial effect, whereas both supplements induced anti-inflammatory gene expression in equol producers. The study was registered at clinicaltrials.gov as NCT01556737.
© 2014 American Society for Nutrition.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25332325     DOI: 10.3945/ajcn.114.088484

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  16 in total

1.  In vitro-in silico-based analysis of the dose-dependent in vivo oestrogenicity of the soy phytoestrogen genistein in humans.

Authors:  Rungnapa Boonpawa; Albertus Spenkelink; Ans Punt; Ivonne M C M Rietjens
Journal:  Br J Pharmacol       Date:  2017-07-11       Impact factor: 8.739

2.  The Dietary Isoflavone Daidzein Reduces Expression of Pro-Inflammatory Genes through PPARα/γ and JNK Pathways in Adipocyte and Macrophage Co-Cultures.

Authors:  Yuri Sakamoto; Junko Kanatsu; Mariko Toh; Ayano Naka; Kazuo Kondo; Kaoruko Iida
Journal:  PLoS One       Date:  2016-02-22       Impact factor: 3.240

Review 3.  Osteoporosis: Modern Paradigms for Last Century's Bones.

Authors:  Marlena C Kruger; Frances M Wolber
Journal:  Nutrients       Date:  2016-06-17       Impact factor: 5.717

4.  Soy Improves Cardiometabolic Health and Cecal Microbiota in Female Low-Fit Rats.

Authors:  Tzu-Wen L Cross; Terese M Zidon; Rebecca J Welly; Young-Min Park; Steven L Britton; Lauren G Koch; George E Rottinghaus; Maria R Cattai de Godoy; Jaume Padilla; Kelly S Swanson; Victoria J Vieira-Potter
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

Review 5.  Phytochemicals That Influence Gut Microbiota as Prophylactics and for the Treatment of Obesity and Inflammatory Diseases.

Authors:  Lucrecia Carrera-Quintanar; Rocío I López Roa; Saray Quintero-Fabián; Marina A Sánchez-Sánchez; Barbara Vizmanos; Daniel Ortuño-Sahagún
Journal:  Mediators Inflamm       Date:  2018-03-26       Impact factor: 4.711

6.  Pure flavonoid epicatechin and whole genome gene expression profiles in circulating immune cells in adults with elevated blood pressure: A randomised double-blind, placebo-controlled, crossover trial.

Authors:  Diederik Esser; Johanna M Geleijnse; Juri C Matualatupauw; James I Dower; Daan Kromhout; Peter C H Hollman; Lydia A Afman
Journal:  PLoS One       Date:  2018-04-19       Impact factor: 3.240

7.  Soy supplementation: Impact on gene expression in different tissues of ovariectomized rats and evaluation of the rat model to predict (post)menopausal health effect.

Authors:  Mohammed A Islam; Guido J E J Hooiveld; Johannes H J van den Berg; Vera van der Velpen; Albertinka J Murk; Ivonne M C M Rietjens; F X Rolaf van Leeuwen
Journal:  Toxicol Rep       Date:  2018-10-24

Review 8.  Genistein: An Integrative Overview of Its Mode of Action, Pharmacological Properties, and Health Benefits.

Authors:  Javad Sharifi-Rad; Cristina Quispe; Muhammad Imran; Abdur Rauf; Muhammad Nadeem; Tanweer Aslam Gondal; Bashir Ahmad; Muhammad Atif; Mohammad S Mubarak; Oksana Sytar; Oxana Mihailovna Zhilina; Ekaterina Robertovna Garsiya; Antonella Smeriglio; Domenico Trombetta; Daniel Gabriel Pons; Miquel Martorell; Susana M Cardoso; Ahmad Faizal Abdull Razis; Usman Sunusi; Ramla Muhammad Kamal; Lia Sanda Rotariu; Monica Butnariu; Anca Oana Docea; Daniela Calina
Journal:  Oxid Med Cell Longev       Date:  2021-07-19       Impact factor: 6.543

9.  Diverging metabolic effects of 2 energy-restricted diets differing in nutrient quality: a 12-week randomized controlled trial in subjects with abdominal obesity.

Authors:  Sophie Schutte; Diederik Esser; Els Siebelink; Charlotte J R Michielsen; Monique Daanje; Juri C Matualatupauw; Hendriek C Boshuizen; Marco Mensink; Lydia A Afman
Journal:  Am J Clin Nutr       Date:  2022-07-06       Impact factor: 8.472

Review 10.  The impact of equol-producing status in modifying the effect of soya isoflavones on risk factors for CHD: a systematic review of randomised controlled trials.

Authors:  Rahel L Birru; Vasudha Ahuja; Abhishek Vishnu; Rhobert W Evans; Yoshihiro Miyamoto; Katsuyuki Miura; Takeshi Usui; Akira Sekikawa
Journal:  J Nutr Sci       Date:  2016-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.